Pfizer Inc 235 East 42nd St New York Ny 10017 Pma Numbern18286 Supplement Numbers040 Date Received05 27 2022 Decision Date06 24 2022 Product Code Lmf Advisory Committee General Plastic Surgery Supplement Typespecial Immediate Track Supplement Reason Labeling Change Indications Instructions Shelf Life Tradename Expedited Review Granted No

FDA Filings

This page includes the latest FDA filings for Pfizer Inc 235 East 42nd St New York Ny 10017 Pma Numbern18286 Supplement Numbers040 Date Received05 27 2022 Decision Date06 24 2022 Product Code Lmf Advisory Committee General Plastic Surgery Supplement Typespecial Immediate Track Supplement Reason Labeling Change Indications Instructions Shelf Life Tradename Expedited Review Granted No. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Registration(s)

FDA Filings

Device
Company
DeviceDate
PFIZER, INC.235 East 42nd St.new York, NY 10017 PMA NumberN18286 Supplement NumberS040 Date Received05/27/2022 Decision Date06/24/2022 Product Code LMF  Advisory Committee General & Plastic Surgery Supplement Typespecial (immediate Track) Supplement Reason Labeling Change - Indications/instructions/shelf Life/tradename Expedited Review Granted? No
(Gelfoam (absorbable gelatin) Sterile Sponge)2022-06-24

Related Finance Registrations

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.